Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation

First quarter revenue of $287 million, with 59% gross margin Positive net income of $2 million and Adjusted EBITDA of $100 million* Rescheduling of medical marijuana to Schedule III enabled applications for DEA registration TALLAHASSEE, Fla., May 7, 2026 /PRNewswire/ -- Trulieve Cannabis...